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Abstract
Increasingly, feed additives for livestock, such as amino acids and vitamins, are being produced by Gram-negative
bacteria, particularly Escherichia coli. The potential therefore exists for animals, consumers and workers to be
exposed to possibly harmful amounts of endotoxin from these products. The aim of this review was to assess the
extent of the risk from endotoxins in feed additives and to calculate how such risk can be assessed from the
properties of the additive. Livestock are frequently exposed to a relatively high content of endotoxin in the diet: no
additional hazard to livestock would be anticipated if the endotoxin concentration of the feed additive falls in the
same range as feedstuffs. Consumer exposure will be unaffected by the consumption of food derived from animals
receiving endotoxin-containing feed, because the small concentrations of endotoxin absorbed do not accumulate
in edible tissues. In contrast, workers processing a dusty additive may be exposed to hazardous amounts of
endotoxin even if the endotoxin concentration of the product is low. A calculation method is proposed to
compare the potential risk to the worker, based on the dusting potential, the endotoxin concentration and
technical guidance of the European Food Safety Authority, with national exposure limits.
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Background
Gram-negative bacteria are characterised by having an
outer membrane in which a structural component is lipo-
polysaccharide (LPS). All Gram-negative bacteria contain
LPS. LPS varies in chemical structure, particularly in poly-
saccharide composition, across Gram-negative species and
even among strains of the same species [1–3]. LPS has
endotoxin activity, whose potency varies enormously
among species and their different LPS structures, particu-
larly lipid A [1–3]. Escherichia coli produces a LPS with
exceptionally high endotoxin activity [1, 2].
Feed additives to be used in the European Union must
be assessed by the European Food Safety Authority (EFSA;
http://www.efsa.europa.eu/), before they are authorised.
Among the criteria assessed are safety for the target
animal, safety for the consumer and safety for the user
(workers). Most additives produced by fermentation are
derived from fungi and Gram-positive bacteria, none of
which contain LPS, although some fungi may contain
endotoxin-like activity. However, an increasing number of
amino acid products is appearing that derives from
fermentation with Gram-negative bacteria, particularly
E. coli, because genetic systems are well characterised in
this bacterium. E. coli K-12 is considered safe in most
respects, such as the absence of antibiotic production,
enterotoxins and virulence factors [4, 5]. However, this
long established strain, often considered a ‘laboratory
cripple’ [6], still contains LPS, because it is an essential
structural component of the outer membrane. LPS of
E. coli K-12 is less potent than most other strains, never-
theless it retains at least one-quarter of the endotoxin ac-
tivity of wild-type strains [7–9]. Thus, additives produced
by fermentation using E. coli K-12 have the potential to be
hazardous if LPS passes into the additive. The aim of this
paper was to determine the extent of the risk to workers
handling the additive, to the consumer and to the target
animals from endotoxins in feed additives and to calculate
how such risk can be assessed from the properties of the
feed additive.
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Extremely small amounts of endotoxin (1–4 ng/kg body
weight (bw)) reaching plasma can cause severe systemic ef-
fects in man [10]. When LPS is administered intravenously,
it causes a dose-related increase in serum C-reactive
protein, TNF-α, IL-1β,and IL-6, which further causes
severe fever, diarrhoea, vomiting, and hypotension [10].
Endotoxin plays a central role in the pathogenesis of
septic shock in man [11]. The application of intraven-
ous endotoxin in humans induces a variety of acute
inflammatory responses similar to the early stages of
septic shock [11]. Changes occur in systemic haemo-
dynamics, ventricular function, pulmonary gas exchange
and permeability. A wide variety of inflammatory media-
tors are released which appear to contribute to these re-
sponses. These include the release of proinflammatory
cytokines, including TNF-α, IL-1β, IL-6, and IL-8, activa-
tion of the fibrinolytic system, kallikrein-kinin generation
and phospholipase A2 release [11]. LPS is known to be a
very potent antigen and, as a result, stimulates an intense
host inflammatory response in man [2, 12] and animals
[13], including fish [14]. In cattle, intravenous administra-
tion of 0.4 μg of E. coli endotoxin per kg bw resulted in
many of the symptoms of subacute ruminal acidosis
(SARA), including inflammation, ruminal pH declining
and changes in the microbial community [15]. Thus, if
endotoxin enters into the circulation, severe pathological
responses may occur.
Toxicity by oral ingestion
In their review, the Dutch Committee on Occupational
Standards concluded that evidence that oral ingestion of
endotoxins causes harm was weak in normal, healthy
people [16]. Indeed, oral administration of LPS may even
be therapeutic in allergic and lifestyle-related diseases
[17]. In contrast, systemic exposure to endotoxins escap-
ing from the gut lumen can be associated with severe in-
flammatory disease in man [2, 18] and animals [19–23].
Healthy individuals carry a large intestinal load of LPS
with no harm, and it is generally accepted that in order
for the pathogenesis to occur, the barrier function of the
gut must firstly be compromised, as in inflammatory
bowel disease in man [2, 24], stress in pigs [25],
nematode infection in mice [26] and sub-acute ruminal
acidosis (SARA) in cattle [22]. High endotoxin concen-
trations (>105 IU/ml; [20]) in the rumen are associated
with, but insufficient to cause, increases in acute phase
proteins serum amyloid-A, haptoglobin, and LPS-
binding protein in peripheral circulation usually associ-
ated with SARA [21, 22]. The low pH that accompanies
SARA increases the permeability of the rumen epithe-
lium [27, 28], and may be necessary for systemic tox-
icity to take place.
Effects of endotoxin inhalation
There is abundant evidence in the literature that workers
exposed to high endotoxin levels by inhalation suffer im-
paired lung function. The Dutch expert Committee on
Occupational Safety [29] summarised the evidence as
follows. “The inhalation of endotoxins may cause the fol-
lowing acute symptoms: dry cough, dyspnoea accom-
panied by diminished lung function, fever and general
malaise. After several hours, the following symptoms
may develop: bronchoconstriction, headache and aching
joints. The acute effects have been observed in the
context of research with volunteers and reported in the
outcomes of epidemiological research amongst occupa-
tionally exposed people. It has been demonstrated that,
in asthma sufferers and people with inflammations of
the nasal mucosa, exposure to LPS can lead to bronchial
obstruction, accompanied by increased reactivity. Epi-
demiological research has produced evidence to suggest
that prolonged exposure to endotoxins may lead to
chronic bronchitis and diminished lung function”.
Workers in sewage plants, poultry sheds, sawmills and
materials recycling facilities [29, 30] are particularly ex-
posed to high levels of respirable endotoxins, which
leads to chronic bronchitis and diminished lung function
[29]. Thorn [31] concluded that inhalation of 30–40 μg
LPS was a threshold dose for inducing clinical symptoms
and lung function changes in healthy subjects via an in-
halation challenge. The threshold dose for inducing
changes in blood neutrophils may be less than 0.5 μg
LPS. It is not clear how these values might be inter-
preted in terms of long-term exposure.
Safety for the farmer and factory worker
Two categories of people may be exposed to endotoxins
arising from feed additives, namely farm workers and
workers in the premixture factory, i.e. where minerals/
vitamins/trace nutrients supplements are prepared.
Farmers are routinely exposed to environmental endo-
toxins, presumably arising from animal faeces. Indeed
poultry and pig facilities are among the most hazardous
work places in this respect [29]. Little of the endotoxin
would originate from feed additives, however. Even if
the additive did contain endotoxin, it would already
have been mixed with the feed or with a vitamins/min-
erals pre-mixture. The worker most intimately exposed
to the endotoxins in a feed additive would be the
worker in the premixture factory.
Calculation of endotoxin exposure of the premixture
factory worker
Two key measurements are required to evaluate the po-
tential respiratory hazard associated with endotoxin in
any product, viz. the endotoxin activity of the material
and the amount of exposure by inhalation.
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Several assays are available for measuring endotoxin
activity, and it is uncertain which corresponds best to in-
flammatory potency. Because different LPS molecules
have different endotoxin activities, chemical estimation
of LPS is not appropriate to assess endotoxin content of
additives. Heating of E. coli LPS caused inactivation in
the Limulus amoebocyte lysate (LAL) assay in the same
way as inactivation in the TNFα secretion assay [9]. It is
recognised that the LAL assay has limitations; however,
it is generally accepted for endotoxin measurements in
the EU [29, 32]. Different extraction procedures most
probably account for a large part of the variation in
results [33].
The exposure of workers by inhalation is best measured
by personal monitors on workers or by measurements of
dust in the work environment. Such data are not always
available, so instead it is common to make a conservative
estimate of worker exposure from the dusting potential, as
measured by the Stauber-Heubach method [34]. The likely
exposure time, according to technical guidance of the
EFSA FEEDAP Panel [35] for additives added in premix-
tures, assumes a maximum of 40 periods of exposure per
day, each comprising 20 s = 40 × 20 = 800 s per day. With
an uncertainty factor of 2, maximum inhalation exposure
would occur for 2 × 800 = 1600 s = 0.444 h per day. Again
assuming a respiration volume of 1.25 m3/h [35], the inhal-
ation volume providing exposure to potentially endotoxin-
containing dust would be 0.444 × 1.25 = 0.556 m3 per day.
If the endotoxin content is a IU/g and the dusting potential
is b g/m3, then the endotoxin concentration of the dust
would be a × b IU/m3, and exposure to endotoxin in dust
would therefore be 0.556 × (a × b) IU/day (Table 1).
Exposure limits for the factory worker
The Health Council of the Netherlands [29] proposed a
health-based recommended exposure limit (HBROEL) of
90 IU/m3 (eight-hour time-weighted average) for endo-
toxins in the workplace. The statutory maximum expos-
ure permitted by the UK Health & Safety Executive [30]
is the same. Therefore, the exposure of the factory
worker, in the case of feed additives in the premixture
unit, should be maintained lower than these nationally
respected maxima. Respiration in man may reach
1.25 m3/h according to the EFSA FEEDAP panel [35], so
inhalation volume over an 8-h working day would be
8 × 1.25 = 10 m3. Thus, the maximum permissible total
daily exposure by the user, without protection, would be
10 × 90 = 900 IU. The exposure from the endotoxin con-
centration and dustiness of a product, as calculated
above, can then be compared directly with this proposed
exposure limit (Table 1).
Rylander [36] concluded that a threshold of 10 ng/m3
for an 8-h working day should be applied to prevent
lung inflammation in man. Using the assumptions made
in Table 1 that the endotoxin activity is 20 IU/ng and
the volume of air inhaled in 8 h is 10 m3, a value of
10 × 20 × 10 = 2000 IU can be calculated for the total
maximum acceptable exposure during an 8-h working
day, a value of a similar order of magnitude to the statu-
tory limits adopted above. These values represent a tiny
amount of endotoxin, especially when one considers that
1 μL of gut contents can contain >103 IU of soluble
endotoxin [20], and factory dust in some industries often
exceeds 104 IU/m3 [30].
Safety for farm livestock
Oral toxicity of LPS
Farm livestock are exposed continuously to endotoxins
in their environment [37], including in feed, and to large
quantities of LPS present in Gram-negative bacteria in
the gastrointestinal tract [25, 38]. Nevertheless, given the
potentially toxic effects of endotoxin at small doses, a
cautious approach must be taken to possible risks asso-
ciated with diets containing increased concentrations of
endotoxin.
Reports of the consequences of oral ingestion of endo-
toxin/LPS in farm animals do not seem to be consistent.
In contrast to the adverse effects of parenteral adminis-
tration, for the most part, oral administration of LPS ap-
pears to be safe. In a pig study described by the Health
Council of the Netherlands [16], high dietary doses of
endotoxins did not cause clinical symptoms. Oketani et
al. [39] stated that oral administration of LPS is not
harmful to animals. Schryvers et al. [40] found no
evidence of toxicity when LPS from Pseudomonas
aeruginosa was added in drinking water for mice (intake
7.2 ml/d), either at a concentration of 20 μg/ml for
40 days or 200 μg/ml for 1 day. Repeated oral adminis-
tration of high doses of E. coli LPS had no demonstrable
effect on small intestinal structure and cell proliferation
in rats [41]. Taniguchi et al. [42] found that high doses
of single oral administration of Pantoea agglomerans
LPS had no side-effects in rats. Moreover, oral adminis-
tration of this LPS for 28 days in a repeated-dose study
showed no evidence of hepatotoxicity, nephrotoxicity,
inflammation, or weight decrease in rats. In their review,
Inagawa et al. [17] concluded that these findings demon-
strate that oral administration of LPS is safe for animals,
although the endotoxin activity of P. agglomerans LPS is
unclear and the doses used by Taniguchi et al. [42] were
not described in a way that enables calculation of daily
LPS intake. Furthermore, Inagawa et al. [17] cited litera-
ture describing therapeutic effects of P. agglomerans LPS
in preventing hyperlipidaemia (rabbits), diabetes mellitus
(mice and humans), various infectious diseases (mice and
shrimps), and ulcerative colitis (mice), as well as causing
analgesic effects (mice, rats, and humans). Taniguchi et al.
[42] also claimed beneficial effects of oral LPS. In contrast,
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Cort et al. [43] administered via the feed 40 mg of
Enterobacter agglomerans LPS to 5 pigs and observed
slight to severe signs of endotoxaemia in 3 animals. No
effect was seen following intraruminal infusion of up to
20 mg per animal in goats [43].
The other way of assessing the likely hazard posed by
an endotoxin-containing feed additive is – does the
additive increase significantly the amount of LPS that
may be ingested in the normal course of events in a
typical farm? Animal feed may be contaminated with
endotoxin on a regular basis (Table 2). Cort et al. [43] re-
ported concentrations of 12.4 and 12.9 ng endotoxin/mg,
assayed by the LAL assay, in pig feed and cited other
analyses where values up to 60 ng/mg were found. Details
of the methods of extraction were not provided. The same
authors measured 0.05 ng/mg in hay and 10 ng/mg in
pelleted feed for goats. Corn silage contained 1 IU
endotoxin/mg in samples from the centre of the silo, but
concentrations 200× higher were found in samples taken
from the surface [44]. Two feed samples from a duck-
fattening farm contained 50 and 93 IU/mg [45]. In a study
of feedstuffs for horses by Wolf et al. [46], 47 % of oats
samples and 73 % of straw samples contained >50 ng
endotoxin/mg, or >1000 IU endotoxin/mg. Similar con-
tamination of horse feed materials was observed by
Kamphues et al. [47]. Ratzinger [48] reported a range of
7.5–259 (mean 64.7) ng/mg in pig feed samples from 16
different farms. Liebers et al. [49] used a value of 10 IU
endotoxin/ng LPS. Thus, the endotoxin concentration in
the horse feeds would be 75–2590 IU/mg.
It can be concluded, therefore, that normal feedstuffs
may be contaminated with varying concentrations of
endotoxins, with values of 1000 IU/mg feed not being
unusual, so it can be concluded that oral ingestion of
endotoxin in small quantities would not be harmful, and
would occur normally as a consequence of the
consumption of feedstuffs. Providing the endotoxin
Table 1 Estimation of user exposure to endotoxins from feed additives, including consideration of using filter mask FF P2 or FF P3
as preventative measure
Calculation Identifier Description Amount Source
a Endotoxin content IU/g product
b Dusting potential (g/m3)
a × b c Endotoxin content in the air (IU/m3)
d No of premixture batches made/working day 40 EFSA Guidance on User Safety [35]
e Time of exposure (s) per production of one batch 20 EFSA Guidance on User Safety [35]
d × e f Total duration of daily exposure/worker (s) 800
g Uncertainty Factor 2 EFSA Guidance on User Safety [35]
f × g h Refined total duration of daily exposure/worker (s) 1600
h/3600 i Refined total duration of daily exposure (h) 0.444
j Inhaled air (m3) per 8-h working day 10 EFSA Guidance on User Safety [35]
j/8 × i k Inhaled air during exposure (m3) 0.556
c × k l Endotoxin inhaled (IU) during exposure per 8-h working day
m Health based recommended exposure limit of endotoxin (IU/m3)
per 8-h working day
90 Health Council of the Netherlands [29]
m × j n Health based recommended exposure limit of total endotoxin
exposure (IU) per 8-h working day
900
l/10 Endotoxins inhaled (IU) per 8 h working day reduced by filter
mask FF P2 (reduction factor 10)
l/20 Endotoxins inhaled (IU) per 8 h working day reduced by filter
mask FF P3 (reduction factor 20)








Pig feed 13/60 mg/kg 260/1200 Cort et al. [43]
Hay 0.05 mg/kg 1 Cort et al. [43]
Pelleted goat feed 10 mg/kg 200 Cort et al. [43]
Corn silage 1/200 IU/mg 1/200 Dutkiewicz
et al. [44]
Duck feed 50, 93 IU/mg 50, 93 Scharf [45]
Horse feed oats >50 ng/mg >1000 Wolf et al. [46]





aUsing an activity of 20 IU/ng pure endotoxin, based on values of 12–25 IU/ng
estimated by Luchi and Morrison [7] and 10 IU/ng by Liebers et al. [49]
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concentration in additives produced by fermentation
does not exceed these concentrations, no additional risk
to the target animal would be anticipated. Furthermore,
because ruminants already harbour large amounts of
endotoxin in ruminal digesta, they appear likely to be
more resilient to endotoxin contamination of the feed.
The exception would be animals in which gastroin-
testinal disturbance has compromised the barrier func-
tion of gut tissues. In these animals, excluding any
endotoxin-containing feed ingredients, if possible, would
be recommended.
Inhalation toxicity of endotoxin in the animal
A dusty endotoxin-contaminated feed could presumably
lead to similar problems in target animals to those
described for the human user. The sensitivity of factory
workers to inhalation of endotoxin from the feed
additive prompts the consideration that the animal con-
suming a diet containing an endotoxin-contaminated
additive might similarly be exposed to hazard by inhal-
ation. Only one report was found that indicated respira-
tory problems associated with farm livestock consuming
endotoxin-contaminated feed. Horses consuming feed
contaminated by >50 ng endotoxin/mg feed suffered re-
duced feed intake, increased incidence of respiratory dis-
eases, and elevated body temperature, sudden death,
allergic skin reactions and reduced mobile capacity [47].
LPS induced lung injury in rats, although the dose was
very high (100 mg/m3 over 6 h; [50]). In mice, repeated
low-dose LPS inhalation resulted in airway hyperres-
ponsiveness, associated with a failure to resolve the
proinflammatory response, an inverted macrophage to
dendritic cell ratio, and a significant rise in the inflam-
matory dendritic cell population [51]. A No Observed
Adverse Effect Concentration (NOAEC) was not identified
in any of these studies. The paucity of data indicate that
there is a need for research to provide answers as to the
effect on animal welfare of the inhalation of endotoxins by
farm animals, both from feed and from feed additives.
In the absence of information or guidance on how in-
halation exposure for animals might be calculated, a
similar approach to ingestion exposure would be pru-
dent, namely to assume that feed additives with an endo-
toxin concentration comparable to that found in feed
would not be expected to result in any increased hazard.
Nonetheless, it seems advisable to monitor animals re-
ceiving feed additives produced by E. coli for symptoms
of increased respiratory stress.
Safety for the consumer
In healthy individuals, LPS does not cross the intestinal
barrier easily [52–55] and LPS is metabolised in animal
tissues, particularly the liver [56], and in the lung [25, 29].
Endotoxins that reach the respiratory tract are rendered
harmless by macrophages and polymorphonuclear leuko-
cytes [25, 29]. Thus, endotoxin would not be expected to
accumulate in edible tissues. An endotoxin-contaminated
feed ingredient would therefore not pose a risk to the con-
sumer of animal products.
Conclusions
 In order that the risk to factory workers caused by
endotoxin contamination of additives produced by
fermentation using E. coli or other Gram-negative
bacteria can be assessed, data on dusting potential
(expressed in g/m3, preferably by the Stauber-Heubach
method) should be provided. Dusting potential and
endotoxin activity (LAL assay) can be used to assess
the risk to workers by inhalation.
 If the results of this conservative estimate of worker
exposure indicate that inhalation exposure would be
less than the health-based occupation exposure
limit, it can be concluded that there will be no
health risk for workers. If, however, the results
estimate that exposure may be in excess of the limit,
it must be assumed that workers are at risk, unless
more refined measurements of exposure can be
produced to demonstrate that inhalation exposure of
workers is below the limit.
 To ensure animal safety by oral administration or by
inhalation of dust, when an additive produced by
Gram-negative bacteria is added to the feed at the
proposed use level, the additional endotoxin
concentration of the feed resulting from the additive
should not exceed 1000 IU/mg.
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